Paul-Peter Tak - Founder @ Sitryx Therapeutics

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Founder
Primary Organization
Sitryx Therapeutics

Location Cambridge, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Paul-Peter Tak is the President, CEO, and member of the board of directors of Candel Therapeutics. He previously worked as theSenior Vice President, Chief Immunology Officer, and Global Development Leader at Glaxosmithkline. He attended the Amsterdam University Medical Center.

Jobs

Number of Current Jobs

Number of Past Jobs

Paul-Peter Tak

has

current jobs as

President & CEO

Candel Therapeutics

and

Founder

Sitryx Therapeutics

. Additionally,

Paul-Peter Tak

has had

past job as the

Senior Vice President, Chief Immunology Officer, and Global Development Leader

GlaxoSmithKline

Candel Therapeutics President & CEOSep 2020
Sitryx Therapeutics Founder

Organization Name	Title At Company	Start Date	End Date
GlaxoSmithKline	Senior Vice President, Chief Immunology Officer, and Global Development Leader	2011	2018

Board and Advisor Roles

Number of Current Board & Advisor Roles

Paul-Peter Tak

holds

board and advisor roles as

Member of the Board of Directors

Candel Therapeutics

and

Independent Member Board of Directors

Sitryx Therapeutics

Candel Therapeutics Member of the Board of DirectorsSep 2020
Sitryx Therapeutics Independent Member Board of Directors

Related Hubs

Hub Name	CB Rank (Hub)
Pharmaceutical Companies with Early Stage Venture Funding	39,526
Biotechnology Companies with Early Stage Venture Funding	23,157
Pharmaceutical Companies With Less Than $10M in Revenue (Top 10K)	7,001
Oxford Science Enterprises Portfolio Companies	71,853
Biotechnology Early Stage Companies With More Than $1M in Revenue	27,091
Biotechnology Early Stage Companies With Less Than $50M in Revenue	27,756
Health Care Early Stage Companies With Fewer Than 50 Employees	28,244
Oncology Companies With More Than 10 Employees	11,082
Pharmaceutical Early Stage Companies With Less Than $50M in Revenue	46,449
Pharmaceutical Early Stage Companies With More Than 10 Employees	37,163